Show simple item record

pH-Related Changes in the Absorption of Dipyridamole in the Elderly

dc.contributor.authorO’sullivan, Tami L.en_US
dc.contributor.authorBarnett, Jeffrey L.en_US
dc.contributor.authorBerardi, Rosemary R.en_US
dc.contributor.authorWagner, John G.en_US
dc.contributor.authorRussell, Tanya L.en_US
dc.contributor.authorDressman, Jennifer B.en_US
dc.date.accessioned2006-09-08T19:15:17Z
dc.date.available2006-09-08T19:15:17Z
dc.date.issued1994-01en_US
dc.identifier.citationRussell, Tanya L.; Berardi, Rosemary R.; Barnett, Jeffrey L.; O’Sullivan, Tami L.; Wagner, John G.; Dressman, Jennifer B.; (1994). "pH-Related Changes in the Absorption of Dipyridamole in the Elderly." Pharmaceutical Research 11(1): 136-143. <http://hdl.handle.net/2027.42/41435>en_US
dc.identifier.issn1573-904Xen_US
dc.identifier.issn0724-8741en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/41435
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=7908130&dopt=citationen_US
dc.description.abstractThe bioavailability of dipyridamole, a poorly soluble weak base, was evaluated in 11 healthy, older subjects (≥65 years), 6 with a low fasting gastric pH (control) and 5 with a fasting gastric pH > 5 (achlorhydric), in a randomized, crossover design. Subjects received 50 mg dipyridamole as a single oral dose both with and without pretreatment with 40 mg famotidine (control subjects) or 1360 mg glutamic acid HC1 (achlorhydric subjects). Gastric pH was monitored by Heidelberg radiotelemetric capsule. Gastric emptying of 99m Tc-radiolabeled orange juice was measured. Gastric pH appeared to be a primary determinant in dipyridamole absorption in the elderly. Elevated gastric pH resulted in compromised dipyridamole absorption compared to low-gastric pH conditions in all cases. The administration of glutamic acid hydrochloride to achlorhydric subjects prior to the dose of dipyridamole corrected for the decreased C max and AUC(0–36) exhibited in achlorhydric subjects without pretreatment. T max and k a were slower in achlorhydrics, although pretreatment with glutamic acid HC1 tended to normalize these parameters. Based on these results, it would be beneficial for achlorhydrics to take glutamic acid hydrochloride prior to taking dipyridamole and other medications which need a low gastric pH for complete absorption. The administration of 40 mg famotidine was successful in elevating the gastric pH to >5 in all subjects and maintained it at >5 for at least 3 hr in all subjects tested. The lack of differences in C max and AUC(0–36) with significant differences in T max and k a indicated that control subjects after treatment with famotidine may serve as an adequate model for achlorhydrics with respect to the extent of absorption, but not with respect to the rate of absorption. Gastric emptying of a nutrient liquid was significantly slower in achlorhydric subjects than in control subjects. Finally, fasting serum gastrin appeared to be a relatively reliable and easy method for screening for achlorhydria in the elderly.en_US
dc.format.extent1416047 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherKluwer Academic Publishers-Plenum Publishers; Plenum Publishing Corporation ; Springer Science+Business Mediaen_US
dc.subject.otherMedical Lawen_US
dc.subject.otherPharmacology/Toxicologyen_US
dc.subject.otherPharmacyen_US
dc.subject.otherFamotidineen_US
dc.subject.otherDrug Absorptionen_US
dc.subject.otherGastric PHen_US
dc.subject.otherElderlyen_US
dc.subject.otherBiomedical Engineeringen_US
dc.subject.otherBiochemistry, Generalen_US
dc.subject.otherBiomedicineen_US
dc.subject.otherDipyridamoleen_US
dc.subject.otherGastric Emptyingen_US
dc.subject.otherGlutamic Acid Hydrochlorideen_US
dc.subject.otherHeidelberg Radiotelemetric Capsuleen_US
dc.titlepH-Related Changes in the Absorption of Dipyridamole in the Elderlyen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumCollege of Pharmacy, The University of Michigan, Ann Arbor, Michigan, 48109-1065; The University of Michigan, USAen_US
dc.contributor.affiliationumCollege of Pharmacy, The University of Michigan, Ann Arbor, Michigan, 48109-1065; Marion Merrell Dow Inc., Marion Park Drive, P.O. Box 9627, Kansas City, Missouri, 64134en_US
dc.contributor.affiliationumCollege of Pharmacy, The University of Michigan, Ann Arbor, Michigan, 48109-1065en_US
dc.contributor.affiliationumCollege of Pharmacy, The University of Michigan, Ann Arbor, Michigan, 48109-1065en_US
dc.contributor.affiliationumSchool of Medicine, The University of Michigan Hospital, Ann Arbor, Michigan, 48109en_US
dc.contributor.affiliationumCollege of Pharmacy, The University of Michigan, Ann Arbor, Michigan, 48109-1065; Detroit Receiving Hospital, Department of Pharmacy, 4201 St. Antoine, Detroit, Michigan, 48201en_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid7908130en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/41435/1/11095_2004_Article_304414.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1023/A:1018918316253en_US
dc.identifier.sourcePharmaceutical Researchen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.